MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
← catalyst calendarSponsored by Monopar Therapeutics (industry) · MNPR — their whole pipeline →.
Phase
—
Status
Temporarily not available
Study type
Expanded access
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-09-04
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | — | When the study began enrolling | |
| Primary completion | — | The date the last participant is measured for the primary outcome — the readout window | |
| Study completion | — | The whole study's end, after follow-up | |
| First posted | 2025-05-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-09-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Cancer
- Solid Tumor
- Solid Tumor Cancer
- Oncology
- uPAR-positive Solid Tumor
- Urokinase Plasminogen Activator Receptor-positive Solid Tumor
Intervention
- Biological: MNPR-101-PCTA-177Lu
Related
MNPR · their whole pipeline · Solid Tumors readouts
MNPR's other studiesmost recently updated first
- MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer — · Temporarily not available
- Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors Phase 1 · Active, not recruiting
- Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors Phase 1 · Active, not recruiting
- Camsirubicin + Pegfilgrastim to Determine MTD in ASTS Phase 1 · Terminated
- Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. Phase 2/3 · Terminated
Permalink · MNPR's whole pipeline · Catalyst calendar · Every registered study · What changed